Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Clinical Trial
New HIV/AIDS clinical trial study findings recently were reported by researchers at Columbia University, Department of Medicine
December 3rd, 2008
Research findings, 'Vaginal microbicides and the prevention of HIV transmission,' are discussed in a new report. According to a study from the United States, "Worldwide, nearly half of all individuals living with HIV are now women, who acquire the virus largely by heterosexual exposure. With an HIV vaccine likely to be years away, topical microbicide formulations applied vaginally or rectally are being investigated as another strategy for HIV prevention." "A review of preclinical and clinical research on the development of microbicides formulated to prevent vaginal HIV transmission yielded 118 studies: 73 preclinical and 45 clinical. Preclinical research included...
Source: Vaccine Weekly (2008-12-03)
|
